Status:
UNKNOWN
Vitamin C as an Adjunct in Periodontal Treatment in Type 2 Diabetes Mellitus Patients
Lead Sponsor:
Mahidol University
Conditions:
Diabetes Mellitus Type 2 With Hyperglycemia
Periodontitis
Eligibility:
All Genders
Phase:
PHASE2
Brief Summary
Periodontitis patients with uncontrolled type 2 diabetes mellitus will receive non-surgical periodontal treatment and then be supplemented with daily 500 mg vitamin C (test group) or placebo (control ...
Eligibility Criteria
Inclusion
- uncontrolled type 2 diabetes mellitus
- periodontitis
Exclusion
- complications from diabetes mellitus, e.g., renal insufficiency
- receive insulin
- diseases that interfere with wound healing, e.g., HIV
- receive one of the followings: tetracycline, acetaminophen, NSAID, warfarin, aluminum-containing antacids, barbiturates, phenobarbital, pentobarbital, secobarbital, hormone replacement therapy, chemotherapeutic drug, protease inhibitor
- receive other vitamins or antibiotics within 6 months
- smoking
- pregnancy
Key Trial Info
Start Date :
August 30 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 19 2018
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03269799
Start Date
August 30 2017
End Date
August 19 2018
Last Update
September 1 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Burapha University Hospital
Chon Buri, Thailand, 20130